Palonosetron is a selective 5-HT3 receptor antagonist primarily indicated for the prevention and treatment of chemotherapy-induced and postoperative nausea and vomiting. To support the rigorous analytical… Read more
![Chemical structure of N-(3S)-1-Azabicyclo[2.2.2]oct-3-yl-5,6-dihydro-1-Naphthalenecarboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1227162-75-5-N-3S-1-Azabicyclo2.2.2oct-3-yl-56-dihydro-1-Naphthalenecarboxamide.png&w=3840&q=75)






























Palonosetron is a selective 5-HT3 receptor antagonist primarily indicated for the prevention and treatment of chemotherapy-induced and postoperative nausea and vomiting. To support the rigorous analytical requirements of pharmaceutical development, this category provides a comprehensive range of Palonosetron reference standards, including pharmacopeial and non-pharmacopeial impurities, metabolites, and degradation products. These high-quality compounds are essential for accurate impurity profiling, allowing laboratories to identify and quantify potential process-related or storage-induced impurities that may affect drug potency and safety. Furthermore, stable isotope labelled versions of the parent molecule and its related substances are available to facilitate precise quantification in mass spectrometry and other complex quantitative assays. By utilizing these well-characterized materials, researchers can ensure robust method validation and maintain consistent quality control standards in accordance with global regulatory expectations throughout the drug lifecycle.